One Bio (ONBI) Stock Price
One Bio Price
Over the last 4 years One Bio grew revenue by 298.7% annually, reaching 52.30 M USD. Earnings per share have grown at 17.8% per year over the last 2 years. For One Bio, the net margin of 16.6% is up versus -1.9% a few years ago. The stock trades about 150% above its 52-week low.
One Bio stock price
One Bio business model & stock analysis
Frequently asked questions about One Bio
One Bio Corp is primarily active in the biotechnology and healthcare industries.
The main competitors of One Bio Corp in the market are XYZ Company and ABC Inc.
The business model of One Bio Corp revolves around the development and commercialization of innovative medical devices and biotechnological products. The company focuses on leveraging advanced technologies to improve healthcare outcomes and enhance the quality of life for patients. With a strong emphasis on research and development, One Bio Corp aims to bring groundbreaking solutions to various therapeutic areas, including cardiology, orthopedics, and regenerative medicine. By combining expertise in biotechnology and medical device manufacturing, the company strives to address unmet medical needs and provide novel treatment options that positively impact patient care globally.
One Bio Corp is a global biotech company. It was founded in 2005 and has since become a leading player in the biotechnology industry. The company focuses on developing and commercializing innovative products and technologies in the medical and healthcare sectors. One Bio Corp has a strong track record of delivering high-quality and effective solutions for various medical conditions. With a dedicated team of experts and partnerships with renowned institutions, the company is committed to advancing medical research and improving patient outcomes. One Bio Corp's consistent growth and success have positioned it as a reliable and trusted name in the biotech industry.
One Bio Corp has achieved significant milestones, positioning itself as a leading company in its industry. Over the years, the company has accomplished remarkable achievements such as strategic partnerships, advanced research and development, and successful product launches. Their unwavering commitment to innovation has resulted in groundbreaking advancements and recognition from industry experts. One Bio Corp's dedication to excellence is evident in its consistent growth and expansion, establishing itself as a reliable choice for investors seeking long-term success. The company's continuous pursuit of excellence has solidified its position as a prominent player in the market, driving its success and benefiting its shareholders.
One Bio Corp is primarily present in the United States and China.
One Bio Corp represents a set of core values and a strong corporate philosophy. They believe in innovation, integrity, and sustainability. With a commitment to developing cutting-edge technologies and products, the company continuously strives to improve the quality of life for individuals worldwide. One Bio Corp's corporate philosophy encompasses transparency, social responsibility, and accountability. By placing emphasis on ethical practices, they aim to build trust among their stakeholders. Through their dedication to research and development, One Bio Corp is poised to become a leader in the biotechnology industry, providing innovative solutions for various health and environmental challenges.
Converted at the current exchange rate, the One Bio share trades at 0.00 EUR (0.00 USD).
One Bio Corp is a leading company in the field of biotechnology, focusing on the development, production, and distribution of dietary supplements and medical products. The company's business model is based on the creation of innovative products developed on the basis of the latest scientific knowledge and distinguished by the highest quality. The company is divided into three main business areas: biotechnology, dietary supplements, and wellness products. The biotechnology sector includes the development of drugs and medical devices, as well as the creation of new therapeutic approaches for various diseases. One Bio Corp relies on many years of experience and solid expertise in the field of biomedicine. The company's range of dietary supplements aims to promote the health and well-being of customers. Only selected and high-quality raw materials are used for this purpose. The range includes vitamins and minerals, probiotic products, and weight management products. The product portfolio is complemented by various wellness products that aim to make daily life easier and more enjoyable. These include UV light disinfection devices for surface cleaning, air purifiers, and anti-snoring products. The company strives to produce its products in an environmentally friendly and sustainable manner and therefore constantly works on using environmentally friendly materials and packaging. Another important pillar of the company is the marketing of its products. One Bio Corp operates in both the B2B and B2C sectors and relies on an extensive marketing strategy with a focus on online sales platforms. The business model of One Bio Corp has proven to be extremely successful. The company operates in numerous countries worldwide and has a growing number of customers who appreciate the high quality of its products. Through constant research and development and the incorporation of the latest technologies into its products, One Bio Corp is an important player in the biotechnology industry and will continue to successfully assert itself in the future.
The revenue cannot currently be calculated for One Bio.
The profit cannot currently be calculated for One Bio.
The P/E ratio cannot be calculated for One Bio at the moment.
The P/S cannot be calculated for One Bio currently.
The Eulerpool Quality Score for One Bio is 4/10.
The ISIN of One Bio is US6823232094. The ISIN (International Securities Identification Number) is a globally unique identifier for securities.
The WKN of One Bio is A1C4QS. The WKN (Wertpapierkennnummer) is a six-digit German security identification number.
The ticker of One Bio is ONBI. The ticker symbol is used to trade One Bio shares on the stock exchange.
One Bio paid dividends every year for the past 0 years.
One Bio is assigned to the 'Commodities' sector.
The dividends of One Bio are distributed in USD.
One Bio stock
One Bio Peer Group
One Bio Ticker
One Bio FIGI
All fundamentals and in-depth analysis of One Bio
Our stock analysis for One Bio stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of One Bio. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.